Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer
The present invention relates to substituted 3,3-diphenyl-1,3-dihydro-indol-2-one compounds, and the use of such compounds for the preparation of a medicament for the treatment of cancer in a mammal. It is postulated that treatment of cancers is achieved in which inhibition of protein synthesis and/...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PEDERSEN HANS C KROG-JENSEN CHRISTIAN COULTER THOMAS S MONTALBETTI CHRISTIAN REIGNIER SERGE PRAESTEGAARD MORTEN LINDE VIGGO FELDING JAKOB BUTCHER STEVEN P UDDIN MOHAMMED |
| description | The present invention relates to substituted 3,3-diphenyl-1,3-dihydro-indol-2-one compounds, and the use of such compounds for the preparation of a medicament for the treatment of cancer in a mammal. It is postulated that treatment of cancers is achieved in which inhibition of protein synthesis and/or inhibition of activation of the mTOR pathway is an effective method for reducing cell growth. Examples of such cancers are breast cancer, renal cancer, multiple myeloma, leukemia, glia blastoma, rhabdomyosarcoma, prostate, soft tissue sarcoma, colorectal sarcoma, gastric carcinoma, head and neck squamous cell carcinoma, uterine, cervical, melanoma, lymphoma, and pancreatic cancer. A particular subclass of compounds are represented by the formula (II) wherein at least one of X1 and X2 is a heteroatom substituent, e.g. 6-chloro-3,3-bis-(4-hydroxy-phenyl)-7-methyl-1,3-dihydro-indol-2-one. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2007299102A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2007299102A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2007299102A13</originalsourceid><addsrcrecordid>eNqNyrEKwjAUBdAsDqL-wwPnQBoH6ShRUZcOtnMJ7S0NpC8hiaB_7-IHOJ3lrMXj7OIM_nhq3vLOY_BSy4ZBJiwxvHjMZHmkdoZL1GWQYyozqE2wZQEXChMZywPSVqwm6zN2Pzdif7205iYRQ48c7QBG6bunVuqo67pS-lQd_ltfDNw0Ow</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer</title><source>esp@cenet</source><creator>PEDERSEN HANS C ; KROG-JENSEN CHRISTIAN ; COULTER THOMAS S ; MONTALBETTI CHRISTIAN ; REIGNIER SERGE ; PRAESTEGAARD MORTEN ; LINDE VIGGO ; FELDING JAKOB ; BUTCHER STEVEN P ; UDDIN MOHAMMED</creator><creatorcontrib>PEDERSEN HANS C ; KROG-JENSEN CHRISTIAN ; COULTER THOMAS S ; MONTALBETTI CHRISTIAN ; REIGNIER SERGE ; PRAESTEGAARD MORTEN ; LINDE VIGGO ; FELDING JAKOB ; BUTCHER STEVEN P ; UDDIN MOHAMMED</creatorcontrib><description>The present invention relates to substituted 3,3-diphenyl-1,3-dihydro-indol-2-one compounds, and the use of such compounds for the preparation of a medicament for the treatment of cancer in a mammal. It is postulated that treatment of cancers is achieved in which inhibition of protein synthesis and/or inhibition of activation of the mTOR pathway is an effective method for reducing cell growth. Examples of such cancers are breast cancer, renal cancer, multiple myeloma, leukemia, glia blastoma, rhabdomyosarcoma, prostate, soft tissue sarcoma, colorectal sarcoma, gastric carcinoma, head and neck squamous cell carcinoma, uterine, cervical, melanoma, lymphoma, and pancreatic cancer. A particular subclass of compounds are represented by the formula (II) wherein at least one of X1 and X2 is a heteroatom substituent, e.g. 6-chloro-3,3-bis-(4-hydroxy-phenyl)-7-methyl-1,3-dihydro-indol-2-one.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071227&DB=EPODOC&CC=US&NR=2007299102A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071227&DB=EPODOC&CC=US&NR=2007299102A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PEDERSEN HANS C</creatorcontrib><creatorcontrib>KROG-JENSEN CHRISTIAN</creatorcontrib><creatorcontrib>COULTER THOMAS S</creatorcontrib><creatorcontrib>MONTALBETTI CHRISTIAN</creatorcontrib><creatorcontrib>REIGNIER SERGE</creatorcontrib><creatorcontrib>PRAESTEGAARD MORTEN</creatorcontrib><creatorcontrib>LINDE VIGGO</creatorcontrib><creatorcontrib>FELDING JAKOB</creatorcontrib><creatorcontrib>BUTCHER STEVEN P</creatorcontrib><creatorcontrib>UDDIN MOHAMMED</creatorcontrib><title>Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer</title><description>The present invention relates to substituted 3,3-diphenyl-1,3-dihydro-indol-2-one compounds, and the use of such compounds for the preparation of a medicament for the treatment of cancer in a mammal. It is postulated that treatment of cancers is achieved in which inhibition of protein synthesis and/or inhibition of activation of the mTOR pathway is an effective method for reducing cell growth. Examples of such cancers are breast cancer, renal cancer, multiple myeloma, leukemia, glia blastoma, rhabdomyosarcoma, prostate, soft tissue sarcoma, colorectal sarcoma, gastric carcinoma, head and neck squamous cell carcinoma, uterine, cervical, melanoma, lymphoma, and pancreatic cancer. A particular subclass of compounds are represented by the formula (II) wherein at least one of X1 and X2 is a heteroatom substituent, e.g. 6-chloro-3,3-bis-(4-hydroxy-phenyl)-7-methyl-1,3-dihydro-indol-2-one.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAUBdAsDqL-wwPnQBoH6ShRUZcOtnMJ7S0NpC8hiaB_7-IHOJ3lrMXj7OIM_nhq3vLOY_BSy4ZBJiwxvHjMZHmkdoZL1GWQYyozqE2wZQEXChMZywPSVqwm6zN2Pzdif7205iYRQ48c7QBG6bunVuqo67pS-lQd_ltfDNw0Ow</recordid><startdate>20071227</startdate><enddate>20071227</enddate><creator>PEDERSEN HANS C</creator><creator>KROG-JENSEN CHRISTIAN</creator><creator>COULTER THOMAS S</creator><creator>MONTALBETTI CHRISTIAN</creator><creator>REIGNIER SERGE</creator><creator>PRAESTEGAARD MORTEN</creator><creator>LINDE VIGGO</creator><creator>FELDING JAKOB</creator><creator>BUTCHER STEVEN P</creator><creator>UDDIN MOHAMMED</creator><scope>EVB</scope></search><sort><creationdate>20071227</creationdate><title>Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer</title><author>PEDERSEN HANS C ; KROG-JENSEN CHRISTIAN ; COULTER THOMAS S ; MONTALBETTI CHRISTIAN ; REIGNIER SERGE ; PRAESTEGAARD MORTEN ; LINDE VIGGO ; FELDING JAKOB ; BUTCHER STEVEN P ; UDDIN MOHAMMED</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2007299102A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PEDERSEN HANS C</creatorcontrib><creatorcontrib>KROG-JENSEN CHRISTIAN</creatorcontrib><creatorcontrib>COULTER THOMAS S</creatorcontrib><creatorcontrib>MONTALBETTI CHRISTIAN</creatorcontrib><creatorcontrib>REIGNIER SERGE</creatorcontrib><creatorcontrib>PRAESTEGAARD MORTEN</creatorcontrib><creatorcontrib>LINDE VIGGO</creatorcontrib><creatorcontrib>FELDING JAKOB</creatorcontrib><creatorcontrib>BUTCHER STEVEN P</creatorcontrib><creatorcontrib>UDDIN MOHAMMED</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PEDERSEN HANS C</au><au>KROG-JENSEN CHRISTIAN</au><au>COULTER THOMAS S</au><au>MONTALBETTI CHRISTIAN</au><au>REIGNIER SERGE</au><au>PRAESTEGAARD MORTEN</au><au>LINDE VIGGO</au><au>FELDING JAKOB</au><au>BUTCHER STEVEN P</au><au>UDDIN MOHAMMED</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer</title><date>2007-12-27</date><risdate>2007</risdate><abstract>The present invention relates to substituted 3,3-diphenyl-1,3-dihydro-indol-2-one compounds, and the use of such compounds for the preparation of a medicament for the treatment of cancer in a mammal. It is postulated that treatment of cancers is achieved in which inhibition of protein synthesis and/or inhibition of activation of the mTOR pathway is an effective method for reducing cell growth. Examples of such cancers are breast cancer, renal cancer, multiple myeloma, leukemia, glia blastoma, rhabdomyosarcoma, prostate, soft tissue sarcoma, colorectal sarcoma, gastric carcinoma, head and neck squamous cell carcinoma, uterine, cervical, melanoma, lymphoma, and pancreatic cancer. A particular subclass of compounds are represented by the formula (II) wherein at least one of X1 and X2 is a heteroatom substituent, e.g. 6-chloro-3,3-bis-(4-hydroxy-phenyl)-7-methyl-1,3-dihydro-indol-2-one.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2007299102A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T11%3A35%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PEDERSEN%20HANS%20C&rft.date=2007-12-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2007299102A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |